|
2023
|
Invention
|
Coxsackievirus a6 type strain, and immunogenic composition and use thereof. A coxsackievirus A6 t... |
|
|
Invention
|
Coxsackievirus a10 strain and use thereof. A coxsackievirus A10 strain and a use thereof. Amino a... |
|
2022
|
P/S
|
Chemical preparations for pharmaceutical purposes; vaccines;
diagnostic preparations for medical... |
|
|
Invention
|
Coxsackie virus a16 strain and immunogenic composition and application thereof. Provided is a Cox... |
|
2020
|
Invention
|
Engineered hansenula fungi efficiently expressing ca10 virus-like particles and uses thereof. Han... |
|
|
Invention
|
Hansenula engineered bacterium efficiently expressing ca10 virus-like particle and use thereof. P... |
|
2016
|
Invention
|
Purification of recombinant ev71 virus-like particle and method for preparing vaccine thereof. Th... |
|
2014
|
Invention
|
Method for preparing genotype f mumps attenuated live vaccine. The present invention provides a m... |
|
|
Invention
|
Ev71 virus-like particles and preparation method and application thereof. Hansenula polymorpha AU... |
|
|
Invention
|
Ev71 virus-like particles and preparation method and application thereof. The present invention p... |
|
2011
|
Invention
|
Method for determining free polysaccharide content in meningococcal polysaccharide conjugate. Pro... |
|
|
Invention
|
Hepatitis a virus strain sh and method for adapting same to diploid cells. Disclosed are a novel ... |
